
BOSTON, April 3 (UPI) -- Massachusetts General Hospital and Genzyme Corp. have identified a possible treatment for a chronic lung disease in premature infants.
A study in American Journal of Physiology -- Lung Cellular and Molecular Physiology found a growth factor that plays a major role in lung disease, or bronchopulmonary dysplasia. Inhibiting the activity of this growth factor in an injured newborn lung may decrease the severity or incidence of the disease.
Senior author Dr. Jesse Roberts Jr. said the results are exciting, since bronchopulmonary dysplasia is the most common lung disease of premature infants.
The disease affects about 15 percent of premature infants and leads to chronic lung disease in 10,000 to 20,000 U.S. infants annually. Most of the infants -- 65 percent -- who are affected have a birth weight of less than 1 pound, 10 ounces.
|
|
|
|
|
|
| Additional Health News Stories | |
PORTLAND, Ore., May 25 (UPI) --
Police said Friday they found the woman who apparently abandoned her three children, ages 1-3, with a group of homeless people in a shed in Portland, Ore.
|
WINSTON-SALEM, N.C., May 25 (UPI) --
Arthel "Doc" Watson is hospitalized in critical condition after a fall at his North Carolina home, the 89-year-old folk musician's family said.
|
Cows crash party, drink all the beer ... New home for dog found in trash bag ... Dog wakes sleeping family during fire ... Teen punished for 'Tebowing' at graduation ... UPI Quirks in the News.
|
NICOSIA, Cyprus, May 25 (UPI) --
Turkey says waters off the coast of war-divided Cyprus where Greek Cypriots plan to explore for natural gas lie within its continental shelf, sharpening multi-sided disputes over major fields under the eastern Mediterranean.
|
| Stories | Photos | People | Comments |
View Caption